Mayne Pharma slumps on settlement of court imposed legal undertaking
SYDNEY: Shares in drugs maker Mayne Pharma are down more than 5.2 per cent to
SYDNEY: Shares in drugs maker Mayne Pharma are down more than 5.2 per cent to
FEATURED
Assisted living providers learn strategies to tackle staffing challenges
Senior living operators plan more moderate rental rate growth in 2026
Former city mortuary is now taking new senior residents
Best affordable housing design for Global Awards shortlisted
Planning authorities take wrecking ball to boomer projects
Best social housing community design for Global Awards shortlisted
INNOVATION
